Osteoclast differentiation inhibitors: a patent review (2008 - 2012).
about
Oxidative stress, redox regulation and diseases of cellular differentiation.A vitronectin-derived peptide reverses ovariectomy-induced bone loss via regulation of osteoblast and osteoclast differentiation.Natural polyamines inhibit the migration of preosteoclasts by attenuating Ca2+-PYK2-Src-NFATc1 signaling pathways.
P2860
Osteoclast differentiation inhibitors: a patent review (2008 - 2012).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Osteoclast differentiation inhibitors: a patent review (2008 - 2012).
@en
type
label
Osteoclast differentiation inhibitors: a patent review (2008 - 2012).
@en
prefLabel
Osteoclast differentiation inhibitors: a patent review (2008 - 2012).
@en
P2860
P1476
Osteoclast differentiation inhibitors: a patent review (2008 - 2012).
@en
P2093
Seong Hwan Kim
Seong-Hee Moon
P2860
P304
P356
10.1517/13543776.2013.842556
P407
P577
2013-10-04T00:00:00Z